Neuromuscular stimulation to avoid pulmonary embolisms

Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C607S002000, C607S003000, C607S046000, C607S049000, C607S061000, C600S546000, C600S595000

Reexamination Certificate

active

07542804

ABSTRACT:
A system and method that provide a prophylactic treatment to a person, e.g., a patient, to avoid the occurrence of pulmonary embolisms by the system providing neuromuscular stimulation to a person's lower extremities, e.g., the person's legs, when the system senses that a person has been immobile for an extended period of time. An implantable neuromuscular pacer, such as that described in U.S. Pat. Nos. 5,193,539; 5,193,540; 6,164,284; 6,185,452; 6,208,894; 6,315,721; 6,564,807; and their progeny, may be used to provide to selectively provide such stimulation. Preferably, such a device may be battery powered so that it can operate independent of an external apparatus. In particular, systems and devices of the present invention preferably additionally include an activity monitor, e.g., an accelerometer or the like, that disables or limits stimulation to pronged time periods in which there is limited activity.

REFERENCES:
patent: 5193539 (1993-03-01), Schulman et al.
patent: 5193540 (1993-03-01), Schulman et al.
patent: 5304206 (1994-04-01), Baker et al.
patent: 5324316 (1994-06-01), Schulman et al.
patent: 5759198 (1998-06-01), Karell
patent: 5843142 (1998-12-01), Sultan
patent: 6164284 (2000-12-01), Schulman et al.
patent: 6185452 (2001-02-01), Schulman et al.
patent: 6208894 (2001-03-01), Schulman et al.
patent: 6282448 (2001-08-01), Katz et al.
patent: 6315721 (2001-11-01), Schulman et al.
patent: 6466821 (2002-10-01), Pianca et al.
patent: 6472991 (2002-10-01), Schulman et al.
patent: 6564807 (2003-05-01), Schulman et al.
patent: 6738672 (2004-05-01), Schulman et al.
patent: 6804558 (2004-10-01), Haller et al.
patent: 6845267 (2005-01-01), Harrison et al.
patent: 2002/0193859 (2002-12-01), Schulman et al.
patent: 2003/0078618 (2003-04-01), Fey et al.
patent: 2003/0078634 (2003-04-01), Schulman et al.
patent: 2003/0078643 (2003-04-01), Schulman et al.
patent: 2003/0083698 (2003-05-01), Whitehurst et al.
patent: 2003/0195578 (2003-10-01), Perron et al.
patent: 2004/0082978 (2004-04-01), Harrison et al.
patent: 2004/0153127 (2004-08-01), Gordon et al.
patent: 2004/0158294 (2004-08-01), Thompson
patent: 2004/0183607 (2004-09-01), Moore
patent: 2004/0225335 (2004-11-01), Whitehurst et al.
patent: 2005/0021108 (2005-01-01), Klosterman et al.
patent: 2005/0209644 (2005-09-01), Heruth et al.
patent: 3932405 (1991-04-01), None
Troyk, et al, Development of Bion Technology for Functional Electrical Stimulation: BiDirectional Telemetry, 2001 Proceedings of the 23rd Annual EMBS International Conference, Oct. 25, 2001, pp. 1317-1320, Publisher: IEEE, Published in: Istanbul, Turkey.
Loeb, et al, Bion System for Distributed Neural Prosthetic Interfaces, 2001, pp. 1-23, Publisher: Journal of Medical Engineering and Physics, Published in: Los Angeles, CA.
Loeb, Bion Development at AMI: Clinical Technical Progress, Bion Development at AMI: Clinical Technical Progress, Sep. 6, 2004, Published in: Los Angeles.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Neuromuscular stimulation to avoid pulmonary embolisms does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neuromuscular stimulation to avoid pulmonary embolisms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuromuscular stimulation to avoid pulmonary embolisms will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4143997

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.